Martin Huber

Martin Huber

Amministratore Delegato presso MERSANA THERAPEUTICS, INC.

Patrimonio netto: 924 960 $ in data 31/05/2024

64 anni
Health Technology
Consumer Services

Profilo

Martin H.
Huber
is currently the President, Chief Executive Officer & Director at Mersana Therapeutics, Inc. since 2023.
He is also serving as an Independent Director at Syndax Pharmaceuticals, Inc. since 2021.
Previously, he held positions such as Vice President-Global Pharmacovigilance at Schering-Plough Corp., Chief Medical Officer & Senior Vice President at Tesaro, Inc. from 2015 to 2019, Senior Vice President-Clinical at GSK Plc from 2019 to 2020, Assistant Professor at The University of Texas M.D.
Anderson Cancer Center, and Vice President-Oncology Clinical Research at Merck Research Laboratories Massachusetts LLC from 2012 to 2015.
Dr. Huber's education includes an undergraduate degree from Texas Lutheran University and a doctorate from Baylor College of Medicine.
Additionally, he is currently serving as the President, Head-Research & Development at Xilio Therapeutics, Inc. from 2022 to 2023.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
08/03/2024 48 000 ( 0.06% ) 924 960 $ 31/05/2024
15/04/2024 0 ( -.--% ) - $ 31/05/2024

Posizioni attive di Martin Huber

SocietàPosizioneInizio
MERSANA THERAPEUTICS, INC. Amministratore Delegato 11/09/2023
SYNDAX PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 15/09/2021
Tutte le posizioni attive di Martin Huber

Precedenti posizioni note di Martin Huber

SocietàPosizioneFine
XILIO THERAPEUTICS, INC. Presidente 08/09/2023
GSK PLC Direttore Tecnico/Scientifico/R&S 01/04/2020
TESARO INC Direttore Tecnico/Scientifico/R&S 22/01/2019
Corporate Officer/Principal 01/01/2015
Corporate Officer/Principal 04/11/2009
Vedi nel dettaglio l'esperienza di Martin Huber

Formazione di Martin Huber

Baylor College of Medicine Doctorate Degree
Texas Lutheran University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Martin Huber

Relazioni

100 +

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
MERSANA THERAPEUTICS, INC.

Health Technology

GSK PLC

Health Technology

XILIO THERAPEUTICS, INC.

Health Technology

SYNDAX PHARMACEUTICALS, INC.

Health Technology

Aziende private4

Health Technology

Health Technology

Health Technology

Consumer Services

Vedi le connessioni aziendali